When Marjorie Denham visits patients at the Rex Heart Center, the volunteer does not have to look at her notes. She knows the information she shares by "heart." Denham has had two bypass surgeries, ...
The effects of atherosclerotic CVD risk factors on the associations between the combination of high triglyceride and low HDL-C levels and incident CHD and ischemic stroke are unclear. Individuals with ...
Stroke can have many causes. An atherothrombotic stroke is caused by a clot that forms from plaques that build up within blood vessels in the brain. A new study suggests that people who have this type ...
New Rochelle, NY, April 5, 2012—In most people, high blood levels of the fat known as triglycerides are an early warning sign of type 2 diabetes and metabolic syndrome, but in people of African ...
Triglycerides are the most common type of fat in your body. They are essential for energy storage. However, if triglyceride levels become too high, it can raise your risk of developing heart disease.
Olezarsen decreased levels of triglycerides compared with placebo in patients with moderate hypertriglyceridemia and elevated cardiovascular risk, according to a late-breaking trial presented in a Hot ...
Becky Brown is a professional writer whose mission it is to empower readers. She tells stories that help people make smart, informed decisions about their health and lives. She’s covered everything ...
Add Yahoo as a preferred source to see more of our stories on Google. Tackle high triglyceride levels with these dietitian-approved frozen foods that are packed with fiber and omega-3s. While your ...
Older people who have higher levels of triglycerides, a type of fat, may have a lower risk of dementia and a slower cognitive decline over time compared to people who have lower levels, according to ...
Please provide your email address to receive an email when new articles are posted on . Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with ...
Olezarsen decreased levels of triglycerides compared with placebo in patients with moderate hypertriglyceridemia and elevated cardiovascular risk, according to a late-breaking trial presented in a Hot ...